\-\ Texto\\:\\ \ \(0\)\
\-\ pt\\/ptt\\/inr\\ and\\ blood\\/platelet\\ counts\\ were\\ normal\\.\ \(0\)\
\-\ initial\\ non\\-contrast\\ head\\ ct\\ shows\\ parenchymal\\ hemorrhage\\ within\\ right\\ temporal\\ and\\ parietal\\ lobes\\,\\ with\\ subarachnoid\\ blood\\.\\ \\ right\\ transverse\\ sinus\\ appears\\ hyperdense\\,\\ as\\ do\\ visualized\\ vein\\ of\\ galen\\ and\\ straight\\ sinus\\.\\ \\ mrv\\ images\\ show\\ flow\\ void\\ at\\ right\\ transverse\\ sinus\\,\\ later\\ confirmed\\ with\\ angiography\\.\ \(0\)\
\-\ right\\ transverse\\ sinus\\ thrombosis\ \(1\)\
\-\ hemorrhage\\ in\\ a\\ young\\ adult\\ can\\ be\\ caused\\ by\\ avm\\,\\ hemorrhagic\\ primary\\ or\\ metastatic\\ neoplasm\\,\\ auto\\-immune\\ disease\\,\\ or\\ even\\ hypertension\\.\\ \\ the\\ findings\\ of\\ acute\\ occlusion\\ of\\ venous\\ sinus\\ is\\ more\\ narrow\\,\\ though\\ infiltrating\\ neoplasm\\ would\\ remain\\ in\\ differential\\ along\\ with\\ clot\\.\ \(0\)\
\-\ patient\\ with\\ acute\\ onset\\ of\\ headache\\ and\\ visual\\ disturbances\\ approximately\\ three\\ weeks\\ after\\ beginning\\ oral\\ contraceptives\\ to\\ help\\ control\\ dysfunctional\\ uterine\\ bleeding\\ secondary\\ to\\ fibroids\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ sinus\\:\\ 0\\.11748717930986607\ \(0\)\
\-\ transverse\\:\\ 0\\.07728827129661647\ \(0\)\
\-\ blood\\/platelet\\:\\ 0\\.06628209341328194\ \(0\)\
\-\ auto\\-immune\\:\\ 0\\.061070460476740994\ \(0\)\
\-\ pt\\/ptt\\/inr\\:\\ 0\\.05585882754020005\ \(0\)\
\-\ dysfunctional\\:\\ 0\\.0516511900369262\ \(0\)\
\-\ contraceptives\\:\\ 0\\.05064719460365911\ \(0\)\
\-\ counts\\:\\ 0\\.046439557100385255\ \(0\)\
\-\ galen\\:\\ 0\\.04414345447218088\ \(0\)\
\-\ neoplasm\\:\\ 0\\.043761753021231996\ \(0\)\
\-\ mrv\\:\\ 0\\.04304117271133971\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.04277077570189527\ \(0\)\
\-\ disturbances\\:\\ 0\\.04208001954209246\ \(0\)\
\-\ fibroids\\:\\ 0\\.04122792416384431\ \(0\)\
\-\ void\\:\\ 0\\.04096407965398514\ \(0\)\
\-\ beginning\\:\\ 0\\.03999256287593998\ \(0\)\
\-\ clot\\:\\ 0\\.0374953159960707\ \(0\)\
\-\ remain\\:\\ 0\\.03601629122730337\ \(0\)\
\-\ infiltrating\\:\\ 0\\.0348957229629388\ \(0\)\
\-\ narrow\\:\\ 0\\.034667863192297234\ \(0\)\
\-\ straight\\:\\ 0\\.03433852016479052\ \(0\)\
\-\ uterine\\:\\ 0\\.03296768139190364\ \(0\)\
\-\ angiography\\:\\ 0\\.03228368305952976\ \(0\)\
\-\ adult\\:\\ 0\\.03220239797603941\ \(0\)\
\-\ hyperdense\\:\\ 0\\.032121982268394696\ \(0\)\
\-\ occlusion\\:\\ 0\\.03204241753658615\ \(0\)\
\-\ help\\:\\ 0\\.03204241753658615\ \(0\)\
\-\ acute\\:\\ 0\\.031727508708368345\ \(0\)\
\-\ parenchymal\\:\\ 0\\.03158193915131758\ \(0\)\
\-\ non\\-contrast\\:\\ 0\\.03136186108891072\ \(0\)\
\-\ subarachnoid\\:\\ 0\\.031218641577852865\ \(0\)\
\-\ avm\\:\\ 0\\.030605911997016903\ \(0\)\
\-\ hemorrhagic\\:\\ 0\\.02997898260649772\ \(0\)\
\-\ though\\:\\ 0\\.029800662857495344\ \(0\)\
\-\ control\\:\\ 0\\.02928975562510055\ \(0\)\
\-\ visual\\:\\ 0\\.029126887228249576\ \(0\)\
\-\ even\\:\\ 0\\.028608143833610843\ \(0\)\
\-\ lobes\\:\\ 0\\.028313251253510984\ \(0\)\
\-\ young\\:\\ 0\\.02798321972300553\ \(0\)\
\-\ do\\:\\ 0\\.027891525940345243\ \(0\)\
\-\ bleeding\\:\\ 0\\.027891525940345243\ \(0\)\
\-\ thrombosis\\:\\ 0\\.027579127422203347\ \(0\)\
\-\ parietal\\:\\ 0\\.027449116165736722\ \(0\)\
\-\ right\\:\\ 0\\.02711674313114035\ \(0\)\
\-\ oral\\:\\ 0\\.027072050122988814\ \(0\)\
\-\ caused\\:\\ 0\\.026950449677533166\ \(0\)\
\-\ visualized\\:\\ 0\\.02600700864131192\ \(0\)\
\-\ temporal\\:\\ 0\\.025728502839204033\ \(0\)\
\-\ hypertension\\:\\ 0\\.025329180844362316\ \(0\)\
\-\ confirmed\\:\\ 0\\.024160899271329302\ \(0\)\
\-\ appears\\:\\ 0\\.023915254291708633\ \(0\)\
\-\ venous\\:\\ 0\\.023321696379376908\ \(0\)\
\-\ vein\\:\\ 0\\.023247618962512158\ \(0\)\
\-\ later\\:\\ 0\\.023198636398443034\ \(0\)\
\-\ would\\:\\ 0\\.02286441261971496\ \(0\)\
\-\ headache\\:\\ 0\\.02206755968094585\ \(0\)\
\-\ three\\:\\ 0\\.021658828784563235\ \(0\)\
\-\ initial\\:\\ 0\\.02129009130285194\ \(0\)\
\-\ flow\\:\\ 0\\.021233487795928693\ \(0\)\
\-\ along\\:\\ 0\\.021233487795928693\ \(0\)\
\-\ differential\\:\\ 0\\.020398194205661125\ \(0\)\
\-\ onset\\:\\ 0\\.020281362600940975\ \(0\)\
\-\ approximately\\:\\ 0\\.019878329522974306\ \(0\)\
\-\ show\\:\\ 0\\.019722976951064855\ \(0\)\
\-\ primary\\:\\ 0\\.01903296438267441\ \(0\)\
\-\ weeks\\:\\ 0\\.01823517110451991\ \(0\)\
\-\ head\\:\\ 0\\.01822256624491651\ \(0\)\
\-\ secondary\\:\\ 0\\.01796263132713389\ \(0\)\
\-\ shows\\:\\ 0\\.01766446390773593\ \(0\)\
\-\ blood\\:\\ 0\\.01753692535721278\ \(0\)\
\-\ metastatic\\:\\ 0\\.01617375491440669\ \(0\)\
\-\ more\\:\\ 0\\.016068994806858392\ \(0\)\
\-\ or\\:\\ 0\\.01506049246561966\ \(0\)\
\-\ were\\:\\ 0\\.01458861907285655\ \(0\)\
\-\ can\\:\\ 0\\.014573100394504282\ \(0\)\
\-\ \\,\\:\\ 0\\.014247898185120388\ \(0\)\
\-\ findings\\:\\ 0\\.013675465682631274\ \(0\)\
\-\ after\\:\\ 0\\.01329324212488122\ \(0\)\
\-\ images\\:\\ 0\\.012325292420671834\ \(0\)\
\-\ within\\:\\ 0\\.012256627130722418\ \(0\)\
\-\ by\\:\\ 0\\.010698277468006577\ \(0\)\
\-\ disease\\:\\ 0\\.010501786024178226\ \(0\)\
\-\ normal\\:\\ 0\\.010072274094730082\ \(0\)\
\-\ be\\:\\ 0\\.009907945288300218\ \(0\)\
\-\ as\\:\\ 0\\.009718627863865622\ \(0\)\
\-\ ct\\:\\ 0\\.008987245514225885\ \(0\)\
\-\ at\\:\\ 0\\.008704986111516037\ \(0\)\
\-\ patient\\:\\ 0\\.006440540833957804\ \(0\)\
\-\ to\\:\\ 0\\.006422076818691522\ \(0\)\
\-\ in\\:\\ 0\\.006336800453236916\ \(0\)\
\-\ and\\:\\ 0\\.005413804683675742\ \(0\)\
\-\ is\\:\\ 0\\.00422775021341899\ \(0\)\
\-\ with\\:\\ 0\\.0035189225891696157\ \(0\)\
\-\ of\\:\\ 0\\.0035038737082101782\ \(0\)\
\-\ a\\:\\ 0\\.0029819533971323403\ \(0\)\
\-\ \\.\\:\\ 0\\.0018683966367024354\ \(0\)\
\-\ the\\:\\ 0\\.0010394683060422991\ \(0\)\
